The retatrutide vs tirzepatide analysis evaluates whether the additional efficacy justifies the investigational status and potentially higher cost
The global prevalence of dementia: A systematic review and meta-analysis
Translate this page into: Tumor necrosis factor- antagonists: Side effects and their management Correspondence Address : Sunil Dogra Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh India Abstract Keywords: Management, side effects, tumor necrosis factor- antagonists Introduction Tumor necrosis factor-alpha (TNF-) is a proinflammatory cytokine that plays a prominent role in the pathogenesis of psoriasis and psoriatic arthritis (PsA), rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and many other dermatologic and rheumatologic conditions
In certain embodiments, diffusion of at least one otic agent from the formulation or composition occurs for a time period exceeding 5 minutes, or 15 minutes, or 30 minutes, or 1 hour, or 4 hours, or 6 hours, or 12 hours, or 18 hours, or 1 day, or 2 days, or 3 days, or 4 days, or 5 days, or 6 days, or 7 days, or 10 days, or 12 days, or 14 days, or 18 days, or 21 days, or 25 days, or 30 days, or 45 days, or 2 months, or 3 months, or 4 months, or 5 months, or 6 months, or 9 months, or 1 year
